Talks (14)
GVHD Management
May 20
Assessing GVHD
May 17
Topical Ruxolitinib
May 17
Ruxolitinib
May 17
GVHD Phrophylaxis
May 17
Oral Chronic GVHD
Jan 25
Axatilimab
Jan 18
Murine Acute GVHD
Jan 18
ASH 2021 Poster
Jan 14
Donor CD3
Jan 14
Retrospective Study
Jan 13
REACH3 Trial
Jan 13
MSCs in GVHD
Dec 17
FDA Approval
Dec 17